Ferring Pharmaceuticals (Euflexxa) | About the Brand



Ferring Pharmaceuticals is a Switzerland-based global biopharmaceutical company that focuses in multiple areas of health, namely reproductive and maternal health. As well as gastroenterology and urology. The company has been developing and manufacturing various treatments for both babies and their mothers for over 50 years. Founded by Dr. Fredrik Paulsen Sr. alongside Dr. Eve Paulsen in Sweden in 1950, originally known as Nordiska Hormon Laboratoriet, ultimately adopting the name Ferring four years later. 

Ferring Pharmaceuticals Incorporated has a diverse portfolio of treatments and products, including Euflexxa, a hyaluronic acid-based solution for osteoarthritis pain in the knee. Their list of products includes Menopur, Reprone, Novarel, and Bravelle.  

The company employs over 6500 employees all over the world as of 2017, and they own multiple operating subsidiaries that are located in almost 60 countries. Their marketing reach is no slouch either, with their products reaching over 110 countries, all equating to around $2.4 billion in annual revenue.   


Information on Peak Medical Wholesale is provided for informational purposes only and may not cover all precautions, side effects, and other information about any given product. Peak Medical Wholesale cannot guarantee the accuracy of all information here, including but not limited to instructions for use. Peak Medical Wholesale reserves the right to change product prices at any time before billing customer and cannot guarantee all products listed on the website are available at any given time. All brand names and product images on Peak Medical Wholesale belong to their respective owners and Peak Medical Wholesale is in no way affiliated with the manufacturers of these products. Only qualified and suitably-trained medical practitioners should purchase and use medical products.